Telix to raise $300m and set to list on Nasdaq
MELBOURNE: Telix Pharmaceuticals, the developer of cancer treatments and a favourite of local ... read more
ACCC overstates chemist merger risks claims Barrenjoey
MELBOURNE: The competition regulator entirely ignored a major wholesaler when it warned that ... read more
Telix pulls $300m Nasdaq IPO as investors demand deep discount
MELBOURNE: Cancer treatment hopeful Telix Pharmaceuticals has abruptly pulled plans to raise $US200 ... read more
Dan Murphy harnesses AI and shelf price tech to boost sales
MELBOURNE: Liquor retail giant Dan Murphy’s is increasingly turning to AI to protect ... read more
